Huixin Medical Valley

Raised $14.3M in a Series A round, announced 7 January 2026.

Latest round Series ACountry ChinaSector AI

Round

Funds clinical development of its iNSC-derived dopaminergic cell injection for Parkinson's.

Amount: $14.3M
Stage: Series A
Announced: 7 January 2026
Lead: Jingneng Green Fund
Other investors: BCI Jingneng Guochuang Fund, Fuzhi Investment
Use of funds: Funds clinical development of its iNSC-derived dopaminergic cell injection for Parkinson's.
Checked: Amount and date checked against the press source
Source: Huixin Medical Valley raises Series A news.pedaily.cn

Induced neural stem cell therapies for Parkinson's and nervous system diseases

How much has Huixin Medical Valley raised?

Huixin Medical Valley raised $14.3M in a Series A round, announced on 7 January 2026.

Who invested in Huixin Medical Valley?

Jingneng Green Fund led. Investors include Jingneng Green Fund, BCI Jingneng Guochuang Fund and Fuzhi Investment.